The Effects of Esophageal Varix Eradication on Pericardial Gastric Varix by Endoscopic Injection Sclerotherapy with Ethanolamine Oleate.
- Author:
Dae Ghon KIM
;
Deuk Soo AHN
;
Byung Hyun RHEE
;
Seong Hee LIM
;
Wan Hee YOO
- Publication Type:Original Article
- Keywords:
Esophageal varix;
Pericardial gastric varix;
Endoscopic injection sclerotherapy
- MeSH:
Cause of Death;
Chest Pain;
Classification;
Deglutition Disorders;
Esophageal and Gastric Varices*;
Ethanolamine*;
Female;
Fever;
Fibrosis;
Follow-Up Studies;
Hemorrhage;
Humans;
Hypertension, Portal;
Jeollabuk-do;
Liver Diseases;
Male;
Medical Records;
Oleic Acid*;
Pleural Effusion;
Sclerotherapy*;
Varicose Veins
- From:Korean Journal of Gastrointestinal Endoscopy
1995;15(3):437-447
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Bleeding from esophageal or gastric varix is the most critical and life-threatening complication of portal hypertension and the most common cause of deaths in the patients with cirrhosis. In the management of variceal bleeding, the various therapeutic interventions including operation and nonoperative procedure were tried, but neither of management was successfully achieved. Between February 1992 and November 1994, we performed endoscopic injection sclerotherapy(EIS) in 35 cirrhotic patients who had recently bled from esophageal varices and had a past history of esophageal variceal bleeding in Chonbuk National Univesity Hospital. Among 35 patients, 32 were male and 3 were female. The underlying severity of liver disease was graded A, B or C according to modification of Child-Pugh classification. EIS was repeated every 1 week until the esophageal varices had been complete obliterated and removed. To investigate the effects of esophageal varix eradication by EIS on combined peri- cardial varix, endoscopic examinations were performed both before procedure and after complete EIS sessions and this study was performed to examine a changes of combined pericardial varices after EIS procedure for the treatment of esophageal varices bleeding secondary to portal hypertesion. We reviewed medical records and compared changes or sizes of pericardial varices before and after EIS procedure. Mean follow up peiod was 61 days. Total number of 162 EIS for variceal eradication were performed. Mean session for eradication of esophageal varices was 4.6 per person, mean amount of injected sclerosant was 8.3cc(1-18cc), mean duration of EIS was 39 days, and mean follow up was 62 days after complete EIS procedure. In total 162 EIS procedure, complications associated with EIS including substernal discomfort 53.7%(n=87), substernal chest pain 45.7%(n=74), fever 4.9%(n=8), dysphagia 14.2%(n=23) and pleural effusion 3.1%(n=5), were transient and not required specific management. During the follow-up period, complete disapperance of pericardial varix or reduction of size was appeared in l8 cases(51.4%) among total 35 patients. No significant changes of variceal size before and after procedure were l6 cases(45.7%) and only 1 case(2.9%) was more aggravated. So, these results suggest that EIS procedure of esophageal varix on pericardial varix seems either to improve or to maintain the severity of the pericardial gastric varix without aggravation.
